Could the selective use of GLP-1 drugs be the key to saving over a million dollars in medical claims, or is there more to this story?

Click to read more!

#NewCanaanWesternConnecticutPlanningRegion #CT #CitizenPortal #NewCanaanHealth #BudgetAccountability #PharmaceuticalTransparency

The board's recent meeting revealed key drug decisions for the 2026 affordability review, with several major players like Keytruda and Skyrizi poised for further scrutiny before the crucial November vote.

Get the details!

#OR #PharmaceuticalTransparency #PublicCommentary